AdventHealth
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, AdventHealth sits in the top decile of US sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count).
AdventHealth: 95 sponsored US clinical trials, 16 recruiting.
AdventHealth sponsors 95 registered US clinical trials on ClinicalTrials.gov, 16 of them currently recruiting, and 63 completed. 6 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pancreatic Neoplasms, with 2 trials.
Top-decile sponsor footprint
AdventHealth ranks in the top decile of sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
63 of 72 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
95 total, page 2 of 2
A Thematic Analysis of Compassion Rounds
NCT03648866
CREATION Health Assessment Tool for College Students
NCT03648164
Validation of a CREATION Health Assessment Tool for Patients in a Diabetic Outpatient Population
NCT03686917
Caregiver Study Dr. Phillips
NCT03653871
"Can A Prescribed Walking Program With or Without Monitoring Impact Dizziness in the Older Adults?"
NCT03403400
Building Physician Resiliency Through CREATION Health: A Research Study
NCT03413969
Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks
NCT03245359
Endoscopic Ultrasound Guided Liver Biopsy
NCT03307811
CREATION Health Readmission Risk Assessment Tool
NCT03424382
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis
NCT03152487
Prevena Incision Management System Wound Care
NCT02953769
Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses
NCT02910960
Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction
NCT03054987
Pancreatic Duct Stent for Acute Necrotizing Pancreatitis
NCT03115918
Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses
NCT02911974
EUS-guided Ablation of Pancreatic Cyst Neoplasms
NCT02422147
CREATION Health Lifestyle Intervention
NCT03412175
Randomized Trial for Extraction of Difficult Bile Duct Stones
NCT00852072
Comparison of FCSEMS and Plastic Stents
NCT02685865
Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma
NCT02911363
Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy
NCT02352922
Preliminary Review of Cold and Active Compression Therapy for Traumatic Calcaneus or Ankle Fractures
NCT02498717
Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee
NCT02449369
22 G - 25 G SINS Trial for Pancreatic Masses
NCT02424838
Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Necrotizing Pancreatitis
NCT02084537
Reduction in Symptomatic Esophageal Stricture Formation
NCT02039115
Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
NCT02032784
Intravenous Acetaminophen for Non-Narcotic Postoperative Pain Management Following Knee Arthroscopy
NCT02025634
Evaluation of Injection Techniques in Celiac Plexus Neurolysis
NCT02068677
Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis
NCT02038985
Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct
NCT01815619
Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions
NCT01809028
Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
NCT01815606
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
NCT02068820
Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression
NCT01675908
Trial Comparing 19 and 25-gauge EUS-FNA Needles
NCT01677312
A Comparison of a Sheathed to a Standard Speculum for Visualization of the Cervix
NCT01670630
Impact of Marking Surgical Incision on Patient's Abdomen
NCT01803334
Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal Cancer
NCT02372929
22G FNA Needle vs. 22G ProCore Needle
NCT01394159
The Effect of Lubricating Gel on Patient Comfort During Speculum Insertion.
NCT01289665
Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression
NCT01191814
"Laparoscopic" Cystoscopy Versus Traditional Cystoscopy
NCT01261819
Cost Analysis of Bariatric Surgery in an Employee-based Healthcare System Following Surgery Coverage
NCT02381704
Over-the-Counter Medication Usage
NCT00439348
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 4 | 6 |
Where AdventHealth enrollment is open (later-stage tilt)
16 recruiting of 95 indexed (17% open); 63 completed (66%).
Phase mix: 6 late (III/IV) vs 3 early (I/II) (later-stage heavy).
Top condition: Pancreatic Neoplasms (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AdventHealth: open-pipeline peers nationwide
Peers matched on 95 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
AdventHealth sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 95 trials (± recruiting share)
- Texas A&M University · 95 trials · 23% recruiting
- Masimo Corporation · 96 trials · 3% recruiting
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- University of Tennessee · 96 trials · 13% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Utah · 17% recruiting · 818 trials
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this AdventHealth page
95 registered trials is a research-attention snapshot, not an endorsement of AdventHealth or any single study.
- 16 of AdventHealth's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pancreatic Neoplasms is the condition AdventHealth studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pancreatic Neoplasms trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AdventHealth pipeline card: 95 registered trials from official public datasets.Report a data error.